Kynurenine pathway metabolites modulated the comorbidity of IBD and depressive symptoms through the immune response.

Lai, Weiming; Huang, Ziheng; Li, Sheng; Li, Xiang-Guang; Luo, Ding

Lai, Weiming; Huang, Ziheng; Li, Sheng; Li, Xiang-Guang; Luo, Ding.

Afiliação

Lai W; Department of Pharmaceutical Engineering, School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, China.
Huang Z; Department of Pharmaceutical Engineering, School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, China.
Li S; The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China.
Li XG; Department of Pharmaceutical Engineering, School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, China. Electronic address: xgli@gdut.edu.cn.
Luo D; The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China. Electronic address: doctorluoding@163.com.

Int Immunopharmacol ; 117: 109840, 2023 Apr.

Article em En | MEDLINE | ID: mdl-36827928

Assuntos

Colite Ulcerativa; Cinurenina; Humanos; Cinurenina/metabolismo; Triptofano/metabolismo; Depressão; Inflamação/metabolismo; Comorbidade

Palavras-chave

Depressive symptom; Immune response; Inflammatory bowel disease; Kynurenine pathway

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colite Ulcerativa / Cinurenina Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google